Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $12.30 Analyst target: $20.00 Upside: 62.60%
NeuroPace, Inc. is a medical device company in the United States. The company is headquartered in Mountain View, California.
See the full interactive analysis & chart →Informational only — not investment advice.